Usefulness of pindolol for treatment of neurocardiogenic syncope

This study evaluated the efficacy of pindolol, a noncardioselective β blocker with intrinsic sympathetic activity, on neurocardiogenic syncope using a head-up tilt-table test in 66 patients. Pindolol was equally effective in men and women and the 2 age groups (>60 and

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 2004-11, Vol.94 (9), p.1189-1191
Main Authors: Nair, Nandini, Padder, Farooq A., Kutalek, Steven P., Kantharia, Bharat K.
Format: Article
Language:English
Subjects:
Adolescent
Adrenergic beta-Antagonists - therapeutic use
Adult
Age Factors
Aged
Aged, 80 and over
Biological and medical sciences
Blood Pressure - drug effects
Cardiology. Vascular system
Cardiovascular disease
Clinical trials
Disorders of higher nervous function. Focal brain diseases. Central vestibular syndrome and deafness. Brain stem syndromes
Drug Evaluation
Drug therapy
Female
Follow-Up Studies
Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy
Heart Rate - drug effects
Humans
Male
Medical sciences
Middle Aged
Nervous system (semeiology, syndromes)
Neurology
Pharmacology
Pindolol - therapeutic use
Side effects
Syncope, Vasovagal - drug therapy
Tilt-Table Test
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This study evaluated the efficacy of pindolol, a noncardioselective β blocker with intrinsic sympathetic activity, on neurocardiogenic syncope using a head-up tilt-table test in 66 patients. Pindolol was equally effective in men and women and the 2 age groups (>60 and
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2004.07.093